The global nucleotide market was worth USD 403 million in 2014. It will surpass USD 810 million by 2022. Demand for nucleotides from end-users like food & beverage additives, pharmaceuticals, animal feed additives, and diagnostics research should drive this growth.
Consumers are increasingly becoming aware of the ill effects of savory ingredients, thus boosting the demand for nucleotide-based flavor enhancers. The demand for animal feed additives is increasing due to concerns regarding animal health. The use of nucleotides in diagnostic research is rising. It enables the detection of viruses and some cancers.
Full research report on nucleotide market analysis:
The pharmaceutical industry in Canada and the U.S. generates high demand for nucleotides. Nucleotides are added to nutraceutical products to strengthen the body’s immunity brought down by faulty diet or stress. Health & safety organizations emphasize human safety & fueling, thus propelling the demand for nucleotides. Favorable governmental policies are another advantage.
The nucleotide market is sliced on the basis of applications, technologies, and geographies. Applications comprise animal feed additives, pharmaceuticals, food & beverage additives, diagnostics research, and others. Diagnostics research led the market in 2014, accounting for 43% volumes. Its growth could be aided by research & developments in dietary & yeast derived nucleotides.
Pharmaceuticals earned USD 112 million in 2014. Nucleotides are also incorporated as Active Pharmaceutical Ingredients (APIs) in the production of animal drugs. Food & beverage additives would expand due to demand for flavor enhancers across the regions of Asia Pacific, North America, and Europe.
Request for sample of this research report:
Technologies wise, the nucleotide market is split into gene chips & microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, and others. TaqMan allelic discrimination contributed USD 231 million in 2014. Expansion in diagnostic research should fuel the segment in the forthcoming years. Chronic diseases in Asia Pacific will also propel the same. Gene chips & microarrays generated more than USD 198 million in 2014.
On the basis of geographies, the market is divided into North America, Asia Pacific, Europe, Central & South America, and Middle East & Africa. North America, with 32% volumes in 2014, was the leader. Europe was the second largest nucleotide market due to wide adoption in its pharmaceutical industry. Asia Pacific is predicted to grow at the fastest CAGR (9.6%) during 2015 to 2022.
Leading players in the global market include ThermoFisher Scientific Inc., CJ CheilJedang Corporation, Meihua Group, and Promega Corporation.
View more reports of this category by Grand View Research at:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States